Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-24-084297

President & CEO sold 8,625 shares at an average $145.17 ($1,252,051)

  • President & CEO acquired 8,625 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hassanein Waleed H · President & CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2024-07-15 Exercise or conversion : show line 1 in the form 10b5-1 +8,625 $13.28 $114,540 70,268 D
2024-07-15 Sale : show line 2 in the form 10b5-1 −1,397 $143.61 $200,623 68,871 D
2024-07-15 Sale : show line 3 in the form 10b5-1 −2,540 $144.34 $366,624 66,331 D
2024-07-15 Sale : show line 4 in the form 10b5-1 −2,046 $145.54 $297,775 64,285 D
2024-07-15 Sale : show line 5 in the form 10b5-1 −2,342 $146.39 $342,845 61,943 D
2024-07-15 Sale : show line 6 in the form 10b5-1 −300 $147.28 $44,184 61,643 D
Open-market sales · 8,625 sh · avg $145.17 · $1,252,051

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-07-15 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −8,625 122,125 D
Loading xslF345X05/ownership.xml…